STOCK TITAN

Lifeward (LFWD) Insider Adds 35.9K Shares via RSUs – Neutral Impact

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Form 4 filing for Lifeward Ltd. (LFWD) discloses one routine equity award to non-executive director Randel Richner.

  • Transaction: On 01-Aug-2025 the director received 35,920 restricted stock units (RSUs) of ordinary shares (par NIS 1.75) at $0 cost.
  • Vesting schedule: RSUs vest in four equal quarterly instalments beginning three months after the grant date.
  • Post-grant holdings: Richner now indirectly owns 57,487 shares through the company ESOP.
  • No derivative securities, sales, or open-market purchases were reported.

The filing reflects standard board compensation intended to align director interests with shareholders. The modest share count suggests immaterial dilution at the company level and no immediate cash impact.

Positive

  • Increased insider alignment: Director’s ownership rises to 57,487 shares, modestly strengthening governance incentives.

Negative

  • None.

Insights

TL;DR – Routine RSU grant; neutral impact.

The 35.9k-share RSU award is typical for board compensation plans and vests over one year, encouraging continued service. Because no shares were sold and the award is small relative to likely LFWD float, market impact and dilution are negligible. The grant marginally increases insider ownership, a slight positive for alignment, but does not change fundamentals or guidance, so overall investor impact is neutral.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Richner Randel

(Last) (First) (Middle)
C/O LIFEWARD LTD.
200 DONALD LYNCH BLVD.

(Street)
MARLBOROUGH MA 01752

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Lifeward Ltd. [ LFWD ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
08/01/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Ordinary Shares, par value NIS 1.75 per share 08/01/2025 A 35,920(1) A $0.00 57,487 I ESOP
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents 35,920 ordinary shares, par value NIS 1.75 per share, issuable upon the vesting of restricted stock units ("RSUs") granted on August 1, 2025 (the "Grant Date") under the Lifeward Ltd. 2025 Incentive Compensation Plan. The RSUs vest ratably in four equal quarterly installments starting three months following the Grant Date.
/s/ Almog Adar, as Attorney-in-Fact 08/07/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did the LFWD Form 4 report?

It reported a grant of 35,920 RSUs to director Randel Richner on 01-Aug-2025.

Does the filing involve any share sales?

No. The transaction was an equity award at $0 cost; no shares were sold.

How many LFWD shares does the director now own?

After the grant, Richner beneficially owns 57,487 ordinary shares through the ESOP.

When will the RSUs vest?

The award vests in four equal quarterly instalments starting three months after 01-Aug-2025.

Is this filing considered material to investors?

It is generally viewed as routine board compensation with minimal dilution and neutral market impact.
Lifeward Ltd

NASDAQ:LFWD

LFWD Rankings

LFWD Latest News

LFWD Latest SEC Filings

LFWD Stock Data

9.93M
17.97M
2.07%
2.89%
7.44%
Medical Devices
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Link
Israel
MARLBOROUGH